Galectin Therapeutics (NASDAQ: GALT) is applying its leadership in galectin science and drug development to create new therapies for fibrotic disease and cancer. Drug candidates based on the Company’s unique carbohydrate technology target galectin proteins which are key mediators of biologic and pat... Read more
Arthritis Knee Pain Centers
2 followers
Bristol-Myers Squibb
278 followers
NYU Langone Health
35 followers
West Pharmaceutical Services
11 followers
Curia Global
8 followers
AbbVie
305 followers
Navitus Health
6 followers
HistoSonics
5 followers
Xeris Pharmaceuticals
3 followers
Corcept Therapeutics
4 followers
Rocket Pharmaceuticals
4 followers